| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
|
| Product No. |
CAS No. |
Name |
Category |
| TP1045M |
649735-41-1 |
4-(4-fluoro-2-methyl-1H-indol-5-yloxy) -5-methylpyrrolo[1,2-f][1,2,4]triazin-6-ol |
Intermediates of API
|
| TP1046A |
656247-17-5, 790241-30-4 (methanesulfonate), 959761-73-0 (HCl) |
BIBF1120; Vargatef |
Inhibitors of VEGFR pathways
|
| TP1046A |
656247-17-5, 790241-30-4 (methanesulfonate), 959761-73-0 (HCl) |
BIBF1120; Vargatef |
Inhibitors of PDGFR pathways
|
| TP1046M |
649736-30-1 |
2-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yl)propan-2-ol |
Intermediates of API
|
| TP1047A |
1174046-72-0, 1174161-83-1 (HCl) |
BMS 794833 |
Inhibitors of VEGFR pathways
|
| TP1047M |
649736-29-8 |
methyl 4-(4-fluoro-2-methyl-1H-indol-5-yloxy) |
Intermediates of API
|
| TP1048A |
649735-46-6 |
Brivanib; BMS-540215 |
Inhibitors of VEGFR pathways
|
| TP1048M |
288385-88-6 |
4-Fluoro-5-hydroxy-2-methylindole |
Intermediates of API
|
| TP1049A |
649735-63-7 |
Brivanib alaninate；BMS-582664 |
Inhibitors of VEGFR pathways
|
| TP1049M |
427878-41-9 |
Ethyl 4-chloro-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carboxylate |
Intermediates of API
|
| TP1050A |
288383-20-0, 857036-77-2 (Maleic acid) |
Cediranib; AZD2171 |
Inhibitors of VEGFR pathways
|
| TP1050M |
427878-70-4 |
5-Methyl-4-oxo-3,4-dihydro-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid ethyl ester |
Intermediates of API
|
| TP1051A |
693228-63-6, 1067881-58-6 |
CYC116 |
Inhibitors of VEGFR pathways
|
| TP1051M |
427878-69-1 |
Diethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate |
Intermediates of API
|
| TP1052A |
405169-16-6 |
Dovitinib; TKI-258 |
Inhibitors of VEGFR pathways
|
| TP1052A |
405169-16-6 |
Dovitinib; TKI-258 |
Inhibitors of PDGFR pathways
|
| TP1052M |
5448-16-8 |
Diethyl 3-methyl-1H-pyrrole-2,4-dicarboxylate |
Intermediates of API
|
| TP1053A |
852433-84-2, 405169-16-6 (free base) |
Dovitinib Dilactic acid; TKI258 Dilactic acid |
Inhibitors of VEGFR pathways
|
| TP1053A |
852433-84-2, 405169-16-6 (free base) |
Dovitinib Dilactic acid; TKI258 Dilactic acid |
Inhibitors of PDGFR pathways
|
| TP1053M |
2999-46-4 |
Ethyl isocyanoacetate |
Intermediates of API
|
|
|
|
